(1)
Sadeghi, S.; Goodarzi, A. Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective. Dermatol Pract Concept 2022, 12 (4), e2022178. https://doi.org/10.5826/dpc.1204a178.